These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7500228)

  • 1. The cognitive structure underlying heroin-injecting behaviour.
    Finnigan F
    J Drug Educ; 1995; 25(3):281-7. PubMed ID: 7500228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment.
    Gossop M; Griffiths P; Powis B; Strang J
    AIDS Care; 1993; 5(2):159-68. PubMed ID: 8392383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of drug treatment for heroin sniffers: a protective factor against moving to injection?
    Kelley MS; Chitwood DD
    Soc Sci Med; 2004 May; 58(10):2083-92. PubMed ID: 15020021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A difficult confrontation for some].
    Musset T; Rau B; François A
    Krankenpfl Soins Infirm; 2013; 106(11):68-71. PubMed ID: 24479229
    [No Abstract]   [Full Text] [Related]  

  • 6. How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples.
    Strang J; Griffiths P; Powis B; Abbey J; Gossop M
    Drug Alcohol Depend; 1997 Jun; 46(1-2):115-8. PubMed ID: 9246559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
    Gossop M; Stewart D; Marsden J; Kidd T; Strang J
    Addict Behav; 2004 Aug; 29(6):1085-94. PubMed ID: 15236809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial accessibility of drug treatment facilities and the effects on locus of control, drug use, and service use among heroin-injecting Mexican American men.
    Kao D; Torres LR; Guerrero EG; Mauldin RL; Bordnick PS
    Int J Drug Policy; 2014 May; 25(3):598-607. PubMed ID: 24440123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
    Hakansson A; Medvedeo A; Andersson M; Berglund M
    Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of heroin dependence and HIV risk. I. Sexual behaviour.
    Gossop M; Griffiths P; Powis B; Strang J
    AIDS Care; 1993; 5(2):149-57. PubMed ID: 8329480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Working with heroin sniffers: clinical issues in preventing drug injection.
    Casriel C; Des Jarlais DC; Rodriguez R; Friedman SR; Stepherson B; Khuri E
    J Subst Abuse Treat; 1990; 7(1):1-10. PubMed ID: 2313766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What happens when contingency management treatment ends? A tale of two clients.
    Petry NM; Kelley L; Brennan M; Sierra S
    Am J Addict; 2008; 17(3):241-4. PubMed ID: 18464002
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 15. Smoking heroin with cannabis versus injecting heroin: unexpected impact on treatment outcomes.
    Morgan N; Daniels W; Subramaney U
    Harm Reduct J; 2019 Dec; 16(1):65. PubMed ID: 31805971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of oral slow release morphine for maintenance treatment in heroin addicts: a 6-month open noncomparative study.
    Vasilev GN; Alexieva DZ; Pavlova RZ
    Eur Addict Res; 2006; 12(2):53-60. PubMed ID: 16543739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of adolescents in residential treatment for heroin dependence.
    Gordon SM; Mulvaney F; Rowan A
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):593-603. PubMed ID: 15540495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence.
    Schroeder JR; Epstein DH; Umbricht A; Preston KL
    Addict Behav; 2006 May; 31(5):868-79. PubMed ID: 16085366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.